论文部分内容阅读
由上海医疗器械研究所领衔研究,上海雷硕医疗器械有限公司独家生产的“固有荧光早期癌症诊断仪”是我国首批发明专利申请中的专利产品,也是中国唯一在世界上领先的医疗器械,继获得中国专利后又先后获得了美国、日本的专利。它对早期恶性肿瘤的高分辨率和高检出率为彻底根治癌症,挽救生命提供了时间和机会。继中国之后世界各国对相关技术的研究、运用也在日趋发展,而我国该产品的市场拓展却举步维艰,随着我国该产品专利保护期的日趋逼近,该“诊断仪”若不尽快走出国门,将丧失国际市场的竞争优势。 癌症是人类疾病中的顽症,近几年虽然世界各国包括我国对癌症的诊断和治疗技术已经有了很大的发展,但是
Led by Shanghai Institute of Medical Device Research, Shanghai Lei Shuo Medical Devices Co., Ltd. exclusive production of “inherent fluorescence early cancer diagnostic instrument” is China's first batch of invention patent applications in the patented product, but also China's only in the world's leading medical equipment, After obtaining the Chinese patent, it successively obtained the patents of the United States and Japan. Its high resolution and high detection rate of early malignant tumors provide time and opportunity to completely eradicate cancer and save lives. After China, all countries in the world research and application of related technologies are also developing day by day. However, the market expansion of this product in our country is struggling. With the approaching of patent protection period in China, if the “diagnostic instrument” is not going out of the country as soon as possible, Will lose the competitive advantage of the international market. Cancer is a chronic disease in human diseases. In recent years, although all countries in the world, including our country, have made great progress in the diagnosis and treatment of cancer,